Yoon, D. H., Ryu, M., Park, Y. S., Lee, H. J., Lee, C., Ryoo, B., . . . Kang, Y. (2012). Phase II study of everolimus with biomarker exploration in patients with advanced gastric cancer refractory to chemotherapy including fluoropyrimidine and platinum. Nature Publishing Group.
Chicago-стиль цитированияYoon, D H., et al. Phase II Study of Everolimus With Biomarker Exploration in Patients With Advanced Gastric Cancer Refractory to Chemotherapy Including Fluoropyrimidine and Platinum. Nature Publishing Group, 2012.
MLA-цитированиеYoon, D H., et al. Phase II Study of Everolimus With Biomarker Exploration in Patients With Advanced Gastric Cancer Refractory to Chemotherapy Including Fluoropyrimidine and Platinum. Nature Publishing Group, 2012.
Предупреждение: эти цитированмия не могут быть всегда правильны на 100%.